Global Health Limited (NSE: MEDANTA), ISIN INE474Q01031 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
MEDANTA last traded at ₹1432.60 (+2.47%), with a 52-week range of ₹955.20 to ₹1455.85 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 33.00%, FIIs 9.46%, DIIs 16.89%, mutual funds 16.03%.
EquiSense Score (ECS): 71/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.